Oncoinvent, a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers, today announced that the first patient has been dosed in its Phase 2 study of Radspherin® ...

The United States dolomite market is expected to grow at a CAGR of 5.5% from 2024 to 2034, driven primarily by rising environmental standards. Stricter regulations aimed at reducing water pollutants ...

A 14-month longitudinal study was conducted in Porto Velho, Rondônia, western Brazilian Amazon. Monthly, 21 permanent water ...

These tiny tablets have been providing relief to overfull tummies for nearly a century, earning them the top spot on Reader's Digest's Most Trusted Brands list.